5.68

0.70% -0.04

Bausch Health Companies Inc (BHC)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché BHC Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$5.72

Aprire:

$5.76

Volume 24 ore:

983.09K

Relative Volume:

0.48

Capitalizzazione di mercato:

$2.12B

Reddito:

$10.27B

Utile/perdita netta:

$120.00M

Rapporto P/E:

13.71

EPS:

0.4142

Flusso di cassa netto:

$949.99M

1 W Prestazione:

+7.98%

1M Prestazione:

+14.52%

6M Prestazione:

-7.04%

1 anno Prestazione:

+30.88%

Intervallo 1D:

$5.68

$5.85

Intervallo di 1 settimana:

$5.225

$5.85

Portata 52W:

$4.28

$8.685

Bausch Health Companies Inc Stock (BHC) Company Profile

Nome

Bausch Health Companies Inc

Settore

Healthcare (1110)

Industria

Drug Manufacturers - Specialty & Generic (83)

Telefono

514-744-6792

Indirizzo

2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC

Dipendente

20,300

Cinguettio

Prossima data di guadagno

2024-10-30

Ultimi documenti SEC

BHC's Discussions on Twitter

Compare BHC vs TAK, ZTS, HLN, TEVA, UTHR

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
BHC Bausch Health Companies Inc	5.68	2.09B	10.27B	120.00M	949.99M	0.4142
TAK Takeda Pharmaceutical Co Adr	17.85	57.12B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	121.11	49.56B	9.47B	2.67B	2.28B	6.0218
HLN Haleon Plc Adr	9.70	43.86B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	31.77	35.89B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	578.54	25.06B	3.18B	1.33B	1.04B	27.90

Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-12-09	Iniziato	Barclays	Equal Weight
2024-08-02	Downgrade	Piper Sandler	Neutral → Underweight
2024-07-10	Iniziato	Raymond James	Mkt Perform
2023-09-20	Aggiornamento	Jefferies	Hold → Buy
2023-06-16	Downgrade	TD Cowen	Outperform → Market Perform
2022-07-29	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2022-07-29	Downgrade	Truist	Buy → Hold
2022-07-28	Downgrade	JP Morgan	Overweight → Neutral
2022-06-13	Ripresa	JP Morgan	Overweight
2021-03-24	Downgrade	BofA Securities	Neutral → Underperform
2021-02-17	Aggiornamento	RBC Capital Mkts	Sector Perform → Outperform
2021-01-22	Downgrade	Piper Sandler	Overweight → Neutral
2020-09-17	Aggiornamento	BofA Securities	Underperform → Neutral
2020-08-24	Reiterato	H.C. Wainwright	Buy
2020-06-17	Reiterato	H.C. Wainwright	Buy
2020-04-24	Iniziato	Citigroup	Buy
2020-04-02	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2020-01-29	Downgrade	Wolfe Research	Outperform → Peer Perform
2020-01-22	Aggiornamento	Wells Fargo	Underweight → Equal Weight
2019-12-12	Aggiornamento	JP Morgan	Neutral → Overweight
2019-12-02	Iniziato	Goldman	Neutral
2019-10-25	Iniziato	Cowen	Outperform
2019-09-12	Iniziato	Guggenheim	Buy
2019-08-15	Aggiornamento	TD Securities	Hold → Buy
2019-07-19	Iniziato	Wolfe Research	Outperform
2019-06-11	Ripresa	Barclays	Overweight
2019-05-13	Aggiornamento	JP Morgan	Underweight → Neutral
2019-03-20	Iniziato	SunTrust	Buy
2019-01-02	Aggiornamento	Piper Jaffray	Neutral → Overweight
2018-11-05	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2018-09-13	Aggiornamento	Piper Jaffray	Underweight → Neutral

Mostra tutto

Bausch Health Companies Inc Borsa (BHC) Ultime notizie

Apr 14, 2026

Bausch Health Companies Inc. and Ortho Dermatologics Announces Launch Of Biafine Skin Recovery Emulsion Through Convenient Online Ordering - marketscreener.com

Apr 14, 2026

Bausch Health rises after $300M worth insider purchase (update) - MSN

Apr 14, 2026

Bausch Health launches Biafine skincare emulsion online in U.S. By Investing.com - Investing.com Canada

Apr 14, 2026

French skin cream sold since 1971 is now available online in the U.S. - Stock Titan

Apr 14, 2026

Apr 13, 2026

Patterns Watch: Can Bausch Health Companies Inc expand into new markets - baoquankhu1.vn

Apr 13, 2026

What makes Bausch Health (BHC) appear so attractive - MSN

Apr 13, 2026

Market Wrap: Is Bausch Health Companies Inc subject to activist investor interestWeekly Trend Summary & Precise Swing Trade Alerts - baoquankhu1.vn

Apr 13, 2026

Dermatology Devices Market to Reach $25.6 Billion by 2030, Driven by Rising Skin Cancer Incidence and Aesthetic Demand - GlobeNewswire Inc.

Apr 13, 2026

Forecast Cut: Will Bausch Health Companies Inc announce a stock splitWeekly Market Outlook & Real-Time Market Sentiment Reports - baoquankhu1.vn

Apr 13, 2026

Earnings Update: How does Bausch Health Companies Inc perform in inflationary periods2026 Snapshot & Low Risk High Win Rate Picks - baoquankhu1.vn

Apr 13, 2026

Apr 10, 2026

US Market Recap: Is Bausch Health Companies Inc likely to announce a buybackQuarterly Profit Review & Accurate Entry/Exit Alerts - baoquankhu1.vn

Apr 10, 2026

Analyst Downgrade: Whats the outlook for Bausch Health Companies Incs sectorBreakout Watch & Weekly Top Gainers Trade List - baoquankhu1.vn

Apr 10, 2026

Apr 09, 2026

Global Keloid Treatment Market Outlook | North America, Asia Pacific, Europe Lead | Bausch Health, Sciton, Galderma Drive Multi-Modal Dermatology Innovation - Morningstar

Apr 09, 2026

Street Watch: Is Bausch Health Companies Inc subject to activist investor interest2026 Sentiment & Stock Portfolio Risk Control - baoquankhu1.vn

Apr 09, 2026

Apr 08, 2026

Bausch Health Releases Additional Proxy Materials - National Today

Apr 08, 2026

[ARS] Bausch Health Companies Inc. SEC Filing - Stock Titan

Apr 08, 2026

Bausch Health (NYSE: BHC) outlines 2026 virtual meeting, board slate and say-on-pay vote - Stock Titan

Apr 08, 2026

Bausch + Lomb Receives FDA 510(k) Clearance for Bi-Blade+™ Dual-Port Vitrectomy Cutter and Adaptive Fluidics™ Advanced Update – Company AnnouncementFT.com - Financial Times

Apr 08, 2026

Apr 07, 2026